We work with innovators of biotech, healthcare, science, sustainability, and advanced technology
Viruend, a breakthrough filtration material, captures and kills SARS-CoV-2
Senturion+ launches an advanced, natural material called Viruend that catches and kills at least 25% more SARS-CoV-2 and other viruses than standard N95 masks.
Bioinsider Friday Roundtables Focus on COVID-19 Immunogenicity, Drug Shortages, and Clinical Trials
ZingPR and Bioinsider convene biotech experts to network, exchange ideas and address timely issues in science and healthcare.
Highlights from Bioinsider’s Therapeutic Pipeline for COVID-19 Virtual Meeting
The Therapeutic Pipeline for COVID-19 meeting was the second in Bioinsider’s ‘Together as One’ COVID-19 Virtual Meeting Series. It brought together more than 100 researchers and featured 11 keynote presentations focused on small-molecule and antibody-based approaches. Here’s what we learned.
Biovista's AI identifies two more drugs for treating COVID-19
Biovista applies AI and data science to identify two drugs as potentially effective therapies for blood clots and inflammation caused by COVID-19. That’s six treatments identified to date!
ZingPR teams with Bioinsider to promote COVID-19 virtual meetings
Bioinsider, the leading virtual meeting platform for communication among the scientific, policymaker, and business communities, is partnering with ZingPR for media relations and speaker promotion.
AAPM seeks innovative medical breakthroughs against COVID-19 in the race to save lives
The AAPM facilitates a dialogue between the ‘4 Ps‘ of precision medicine: patients, providers, public health planners, and payers to work together to achieve the goal of delivering improved outcomes at reduced costs.